Antibodies against human cytomegalovirus (hcmv)

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/08 (2006.01) A61K 39/42 (2006.01) C12N 15/13 (2006.01) G01N 33/569 (2006.01) C07K 19/00 (2006.01)

Patent

CA 2672703

The present invention provides novel antibody sequences that bind human cytomegalovirus (hCMV) and neutralize hCMV infection. The novel sequences can be used for the medical management of hCMV infections, in particular for preparing pharmaceutical compositions to be used in the prophylactic or therapeutic treatment of hCMV infections.

La présente invention porte sur de nouvelles séquences d'anticorps qui se lient au cytomégalovirus humain (hCMV) et neutralisent l'infection par le hCMV. Les nouvelles séquences peuvent être utilisées pour le traitement médical des infections par le hCMV, en particulier pour préparer des compositions pharmaceutiques qui doivent être utilisées dans le traitement prophylactique ou thérapeutique des infections par le hCMV.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antibodies against human cytomegalovirus (hcmv) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies against human cytomegalovirus (hcmv), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies against human cytomegalovirus (hcmv) will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1620731

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.